EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence in Valvular Heart Disease: Current Applications and Future Perspectives

Debabrata Dash, Umanshi Dash, Abdul Rauoof Malik, Naeem Hasanfatta, Sreenivas Reddy, Sugandhna Reno Malan

Iberoamerican Journal of Medicine · 05.05.2026 · 8 (2) · 56-65

DOI: 10.53986/ibjm.2026.0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iberoamerican Journal of Medicine, online erschienen am 05.05.2026. Verfasst von Debabrata Dash und 5 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valvular heart disease (VHD) remains a major contributor to global cardiovascular morbidity and mortality, with diagnosis and management relying on complex multimodality imaging and expert interpretation. This narrative review aims to evaluate the current applications and future potential of artificial intelligence (AI) in VHD. A comprehensive literature search was conducted using major databases, including PubMed, Scopus, and Web of Science, focusing on studies published in English that examined AI applications in VHD diagnosis, procedural planning, intraprocedural guidance, and prognostic assessment. Relevant original studies, clinical trials, and review articles were included based on their methodological quality and clinical relevance. Current evidence indicates that AI enhances early detection through accessible modalities such as electrocardiography and chest radiography, while significantly improving the accuracy and reproducibility of echocardiographic assessment. AI also facilitates precise preprocedural planning for transcatheter interventions and offers real-time support during procedures through multimodal image integration. In addition, AI-driven models enable robust risk stratification and prediction of clinical outcomes. Emerging innovations, including in silico trials and robotic-assisted interventions, further highlight AI’s transformative potential. Despite these advances, challenges related to data quality, bias, interpretability, and regulatory oversight remain. Continued validation and integration are essential to realize AI-driven precision medicine in VHD.

Zitieren

APA

Dash, D., Dash, U., Malik, A. R., Hasanfatta, N., Reddy, S., & Malan, S. R. (2026). Artificial Intelligence in Valvular Heart Disease: Current Applications and Future Perspectives. Iberoamerican Journal of Medicine, 8(2), 56-65. https://doi.org/10.53986/ibjm.2026.0010

Vancouver

Dash D, Dash U, Malik AR, Hasanfatta N, Reddy S, Malan SR. Artificial Intelligence in Valvular Heart Disease: Current Applications and Future Perspectives. Iberoamerican Journal of Medicine. 2026;8(2):56-65. doi:10.53986/ibjm.2026.0010

BibTeX
@article{Dash2026,
  author = {Dash, Debabrata and Dash, Umanshi and Malik, Abdul Rauoof and Hasanfatta, Naeem and Reddy, Sreenivas and Malan, Sugandhna Reno},
  title = {Artificial Intelligence in Valvular Heart Disease: Current Applications and Future Perspectives},
  journal = {Iberoamerican Journal of Medicine},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {56--65},
  doi = {10.53986/ibjm.2026.0010}
}
Kostenlos starten →